Novo Nordisk's new CagriSema study to focus on dose escalation and trial length-March 2024-www.financetom.com

Novo Nordisk's new CagriSema study to focus on dose escalation and trial length

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk's new CagriSema study to focus on dose escalation and trial length

Feb 5, 2025 12:55 AM

COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk on

Wednesday said its new trial of its next-generation obesity drug

candidate CagriSema will look at dose escalation and trial

length to further show the drug's potential, after data last

month disappointed the market.

CEO Lars Fruergaard Jorgensen told journalists on a media

call that the company is confident in the drug's biology and

encouraged by what it has seen in the data.

Previous page： Enphase Energy Says US-Made IQ8 Microinverters in Compliance With Build America, Buy America Act Next page： CNN to cut jobs by 6% amid digital push

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Enphase Energy Says US-Made IQ8 Microinverters in Compliance With Build America, Buy America Act

Jan 23, 2025

09:50 AM EST, 01/23/2025 (MT Newswires) -- Enphase Energy ( ENPH ) said Thursday its US-made IQ8 microinverters for residential and commercial clients are now in compliance with the Build America, Buy America Act. The company said the models in compliance with the act are specifically the IQ8HC-72-M-DOM-US and IQ8P-3P-72-E-DOM-US SKUs. The compliance allows the company's microinverters made at its...

CNN to cut jobs by 6% amid digital push

Jan 23, 2025

(Reuters) - Warner Bros Discovery ( WBD )-owned CNN will lay off about 6% of its workforce as the TV news outlet continues to shift its focus toward a more digital-centric strategy, according to an internal memo seen by Reuters on Thursday. Legacy cable networks, a profitable business for decades, have been hit by intense cord cutting by consumers who...

Union Pacific Posts Mixed Q4 Results With Strong EPS Growth And Improved Efficiency Metrics; Stock Gains

Jan 23, 2025

Union Pacific Corporation ( UNP ) shares are trading higher after the company reported mixed fourth-quarter results. Union Pacific ( UNP ) reported operating revenue decline of 1% year-over-year to $6.121 billion, missing the consensus of $6.143 billion. Lower fuel surcharges, an unfavorable business mix, and reduced other revenue impacted operating revenue, partially offset by higher volume and pricing gains....

Pitney Bowes Repays $97 Million of Senior Debt

Jan 23, 2025

09:53 AM EST, 01/23/2025 (MT Newswires) -- Pitney Bowes ( PBI ) said Thursday it is repaying from cash on hand the remainder of about $97 million in senior secured notes due 2028 issued in July 2023 to Oaktree Capital Management. The company said it reaffirms the outlook for 2024 revenue it provided previously. Pitney said in November, it expects...